Health Bulletin 19/October/2023

Published On 2023-10-19 12:21 GMT   |   Update On 2023-10-21 08:34 GMT

Here are the top health stories for the day:


48-Hour Work Week On Cards For Resident Doctors? Policymakers Claim Matter Under Consideration

The long-pending demand of young doctors, which has never been able to see the light of day till now, of having a 48-hour work week might become a reality soon. In fact, the doctors may also get one day off in the week along with this.

While this may seem like a distant dream to many young medicos, an official from the National Medical Commission (NMC) recently informed a leading Daily that the Commission is planning to bring regulations that will ensure that medical students get weekly off, they are provided reasonable time to rest and their working hours do not exceed more than 48 hours in a week. The matter is currently being considered by the Commission.

For more details, check out the link given below:

48-Hour Work Week On Cards For Resident Doctors? Policymakers Claim Matter Under Consideration


Dabur India's units face lawsuits in US, Canada alleging products caused cancer

Indian multinational consumer goods company, Dabur India Ltd met with twin controversies in both India and abroad, as it has received a GST Rs 321 crore notice in India, and on the other hand, its subsidiaries has been subjected to series of lawsuits in U.S. and Canada by the consumers over the allegations that hair relaxer products cause had caused ovarian cancer, uterine cancer and other health issues.

Advertisement

In India, Dabur received a notice from the Government regarding the payment of GST short paid / not paid amounting to Rs. 3,20,60,53,069/- along with applicable interest and penalty.

For more details, check out the link given below:

Dabur In Controversy: Gets Rs 321 Crore GST Notice In India, US Subsidiaries Face Lawsuits On Allegations That Hair Relaxer Products Cause Cancer


Gaza hospital bombing: Israel shares clip of 'Palestinian terrorists' discussing 'failed rocket launch' that killed 500

Doctors hamstrung by dwindling medical supplies rushed Wednesday to save people badly wounded in a massive blast at a Gaza City hospital the day before, performing surgery - often without anaesthesia - on patients lying on floors, as Israel kept up its attacks on the besieged territory.

The Hamas militant group blamed Israel for the massive blast at the al-Ahli Hospital — saying nearly 500 died — while Israel blamed a rocket misfired by other Palestinian militants.

For more details, check out the link given below:

Gaza's Doctors Struggle To Save Hospital Blast Survivors As Middle East Rage Grows


MBBS student dies after jumping from hostel building in Rajasthan

In a shocking incident, first year MBBS student studying at the Dungarpur Medical College comitted suicide by jumping from the third floor of a medical college hostel in Rajasthan's Dungarpur district on Wednesday

Sudhanshi Singh (22) died after jumping from the Dungarpur Medical College hostel, said Head Constable Popatlal. Her suicide note that was written in her hand stated, "After today I will not make a mistake, my promise. Sorry mummy, papa, brother and rohit"

For more details, check out the link given below:

After Today I Will Not Make A Mistake, My Promise: 22 Year Old MBBS Student Jumps To Death From Medical College Hostel Building


No evidence that female nurses are better caregivers

Male nurses face gender discrimination, evident in policies like the 80/20 reservation at institutions like AIIMS. This policy is rooted in stereotypes and biases that assume nursing is exclusively a female profession and that men are incapable of performing nursing duties. Arun GS, general secretary of IPNA, highlights this issue in an interview to The Indian Express.


ICMR successfully tests first long-lasting male contraceptive

The Indian Council of Medical Research (ICMR) has completed a groundbreaking seven-year study on a male contraceptive known as RISUG (Reversible Inhibition of Sperm under Guidance). This study involved 303 healthy male volunteers aged 25-40, who were administered a 60 mg dose of RISUG. The results, published in the International open access journal Andrology, have provided promising insights into the safety and efficacy of this non-hormonal, injectable male contraceptive.

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News